Xbrane Biopharma AB (XBRANE.ST) Q2 2024 Earnings

16MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-3.31
-2.22
-1.13
-0.05

Details

Expected EPS
-0.045042369127608
Actual EPS
-0.09059403477003644
Surprise EPS
-0.05
Surprise Percent
+101.13%

Description

Xbrane Biopharma AB (XBRANE.ST) has reported earnings of -0.09059403477003644 per share for Q2 2024.

0 Comments

Share your thoughts